It’s Differentiate Or Perish At MedImmune’s Oncology iMED

While the greatest area of growth in Medimmune’s oncology innovative medicines unit is immune-modulated therapies, the company is working on a number of other candidates with unique mechanisms of action and testing them early against standard of care biologics.